Imperva (IMPV) Tops Q4 EPS by 29c

Go back to Imperva (IMPV) Tops Q4 EPS by 29c

Oppenheimer Reiterates Outperform Rating on Imperva (IMPV) Following Strong Q4

February 9, 2017 6:24 AM EST

Oppenheimer analyst Shaul Eyal reiterates Outperform rating and $55 price target on Imperva Inc. (NYSE: IMPV), as the company reported strong 2016 fourth quarter results, beating most consensus estimates across the board, while divesting of Skyfence assets.

Eyal comments, "IMPV reported strong 4Q16 results, beating... More